iTBS

iTBS

FDA Clears SAINT Rapid-Acting Brain Stimulation Approach for Those Suffering From Resistant Major Depression
On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach... Read More
In Major Depression, Accelerated rTMS Brain Stimulation Shows Promise
Researchers have obtained encouraging results in an early test of an accelerated form of non-invasive brain stimulation to treat major... Read More